Skip to content

Clinical trials

Bipolar Disorder trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Bipolar Disorder Country / region: Germany Clear all

40 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20045
20052
20063
20073
20081
20095
20102
20111
20122
20141
20153
20161
20172
20211
20221
20231
20254

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed24
Terminated5
Unknown status5
Recruiting3
Active, not recruiting1
Not yet recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca4
Max-Planck-Institute of Psychiatry3
Universitätsklinikum Hamburg-Eppendorf3
Charite University, Berlin, Germany2
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.2
Ludwig-Maximilians - University of Munich2
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.2
RWTH Aachen University2
Technische Universität Dresden2
Brainsway1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Bipolar Disorder40
Schizophrenia8
Depressive Disorder5
Mania5
Psychotic Disorders5
Major Depressive Disorder2
Mental Disorders2
Schizophrenia, Paranoid2
Anorexia Nervosa1
Anxiety Disorders1

Trials

Showing 1 to 25 of 40. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.